LIS
DNA icon

Legacy Investment Solutions’s Ginkgo Bioworks DNA Stock Holding History

Legacy Investment Solutions’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.26K Buy
+112
New +$868 ﹤0.01% 569
2024
Q4 		$1.6K Sell
112
-38
-25% -$326 ﹤0.01% 534
2024
Q3 		$1.29K Buy
+150
New +$1.5K ﹤0.01% 522

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Legacy Investment Solutions's DNA Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Ginkgo Bioworks (DNA) in Q2 2025: 112 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #569 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in DNA as recently as Q4 2024.

Legacy Investment Solutions first reported a position in DNA in Q3 2024 and has held it in 3 quarters since. The position peaked at $1.6K in Q4 2024. 165 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

  • Legacy Investment Solutions held 112 shares of Ginkgo Bioworks worth $1.26K as of Q2 2025.
  • Ginkgo Bioworks was a new Legacy Investment Solutions position in Q2 2025.
  • Ginkgo Bioworks made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #569 holding.
  • Legacy Investment Solutions first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's Ginkgo Bioworks position peaked at $1.6K in Q4 2024.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.